IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CANCER


Year of Award:
2007
Award Type:
R21
Project Number:
CA122904
RFA Number:
RFA-CA-07-002
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
YEE, CASSIAN
Other PI or Project Leader:
N/A
Institution:
FRED HUTCHINSON CAN RES CTR
Immunotherapy of ovarian cancer represents an emerging modality for the treatment of patients with advanced disease. The majority of patients with disease spread beyond the ovaries initially respond to conventional therapy, but most will eventually relaps